The binding of the receptor tyrosine kinase MET, expressed on neutrophils, by the tumor necrosis factor-alpha (TNFα), and its ligand, the Hepatocyte growth factor (HGF), drives the nitric oxide synthase (NOS) and the consequent release of the anti-tumor inflammatory mediator (41). This evidence concerns the gene MET and neoplasm.